Feedback / Questions
misetionamide (GP-2250) - Panavance Therap
https://www.manilatimes.net/2025/06/13/tmt-newswire/globenewswire/panavance-therapeutics-announces-promising-misetionamide-gp-2250-phase-1-clinical-trial-interim-findings-in-pancreatic-cancer-at-bio-2025/2133002
Jun 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next